In conclusion, we were not able to replicate the association of PRS with response to anti-TNFα therapy for patients with IBD, demonstrating insufficient scientific evidence for the use of genetic data to successfully predict response to anti-TNFα therapy in IBD. This evidence concerns the gene TNF and inflammatory bowel disease.